Novartis Pharmaceuticals Corporation v. Actavis Inc

Application Number	Patent Number	External Links
-	US6465504	Espacenet Google Patents
-	US6596750	Espacenet Google Patents

COMPLAINT filed against Actavis Elizabeth LLC, Actavis Group PTC ehf, Actavis Group hf, Actavis Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1043220.) - filed by Novartis AG, Novartis Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharma AG. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(lih) (Entered: 03/22/2012)

2012-03-21

1

Download

COMPLAINT filed against Actavis Elizabeth LLC, Actavis Group PTC ehf, Actavis Group hf, Actavis Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1043220.) - filed by Novartis AG, Novartis Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharma AG. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(lih) (Entered: 03/22/2012)

2012-03-21

2

View

COMPLAINT filed against Actavis Elizabeth LLC, Actavis Group PTC ehf, Actavis Group hf, Actavis Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1043220.) - filed by Novartis AG, Novartis Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharma AG. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(lih) (Entered: 03/22/2012)

2012-03-21

2

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (lih) (Entered: 03/22/2012)

2012-03-21

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/8/2012. Date of Expiration of Patent: '504 4/5/2019; '750 6/24/2017.Thirty Month Stay Deadline: 8/8/2014. (lih) (Entered: 03/22/2012)

2012-03-21

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,465,504; 6,596,750. (lih) (Entered: 03/22/2012)

2012-03-21

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (lih) (Main Document 5 replaced on 3/22/2012) (lih). (Entered: 03/22/2012)

2012-03-21

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Corporation identifying Corporate Parent Novartis AG for Novartis Corporation. (lih) (Entered: 03/22/2012)

2012-03-21

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis AG. (lih) (Entered: 03/22/2012)

2012-03-21

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (lih) (Entered: 03/22/2012)

2012-03-21

1

View

No Summons Issued (lih)

2012-03-21

1

No Actions

CORRECTING ENTRY: The pdf of D.I. 5 has been replaced with the correct version of the document. (lih)

2012-03-22

1

No Actions

Summons Issued with Magistrate Consent Notice attached as to Actavis Elizabeth LLC on 3/23/2012; Actavis Inc. on 3/23/2012. (rwc)

2012-03-23

1

No Actions

SUMMONS Returned Executed by Novartis AG, Novartis Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharma AG. Actavis Inc. served on 3/26/2012, answer due 4/16/2012. (Silver, Daniel) (Entered: 03/26/2012)

2012-03-26

1

View

SUMMONS Returned Executed by Novartis AG, Novartis Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharma AG. Actavis Elizabeth LLC served on 3/26/2012, answer due 4/16/2012. (Silver, Daniel) (Entered: 03/26/2012)

2012-03-26

1

View

MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert J. Gunther, Jr., Lisa L. Pirozzolo and Kevin Prussia - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Pro Hac Verifications)(Silver, Daniel) (Entered: 03/28/2012)

2012-03-28

1

View

Case Assigned to Judge Christopher J. Burke. Please include the initials of the Judge (CJB) after the case number on all documents filed. This case has been randomly selected for direct assignment to a Magistrate Judge. If all parties consent to the case proceeding before a Magistrate Judge, they should submit Form AO 85 (Notice, Consent, and Reference of a Civil Action to a Magistrate Judge), signed by all parties or their attorneys, within sixty (60) days; that is, on or before 5/29/2012. All parties have a right to proceed before a District Judge. Accordingly, this case will be randomly reassigned to a District Judge upon the earlier of: (a) the filing of a case-dispositive motion (e.g., motion to dismiss, motion for judgment on the pleadings, or motion for summary judgment) or (b) the expiration of sixty (60) days without the filing of a signed copy of Form AO 85. No request to extend the sixty day period shall be filed. More information on the Court`s Pilot Program on direct assignment of cases to Magistrate Judges is available in the Court`s Standing Order, dated November 3, 2011, available on the Court`s website. (rjb)

2012-03-28

1

No Actions

SO ORDERED D.I. 11 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert J. Gunther, Jr., Lisa L. Pirozzolo and Kevin Prussia filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 3/30/2012. (dlk)

2012-03-30

1

No Actions

ACKNOWLEDGEMENT OF SERVICE Executed Complaint served on Actavis Group hf and Actavis Group PTC EHF on March 30, 2012 Acknowledgement filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 04/02/2012)

2012-04-02

1

View

Pro Hac Vice Attorney Jane M. Love for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

2012-04-10

1

No Actions

STIPULATION and Order Dismissing Without Prejudice Defendants Actavis Group HF and Actavis Group PTC ehf, Amending Caption to Reflect Same, and Extending Time to Answer or Otherwise Respond to the Complaint by Actavis Elizabeth LLC, Actavis Group PTC ehf, Actavis Group hf, Actavis Inc.. (Fineman, Steven) (Entered: 04/13/2012)

2012-04-13

1

View

SO ORDERED D.I. 13 Stipulation dismissing Without Prejudice Defendants Actavis Group HF and Actavis Group PTC ehf, Amending Caption to Reflect Same and Extending Time to Answer or Otherwise Respond to the Complaint by Actavis Elizabeth LLC, Actavis Inc. Set/Reset Answer Deadlines: Actavis Elizabeth LLC answer due 5/1/2012; Actavis Inc. answer due 5/1/2012.Ordered by Judge Christopher J. Burke on 4/16/2012. (dlk)

2012-04-16

1

No Actions

Pro Hac Vice Attorney Lisa J. Pirozzolo,Kevin S. Prussia,Robert J. Gunther, Jr for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

2012-04-19

1

No Actions

ANSWER to 1 Complaint, and COUNTERCLAIMS against Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation by Actavis Inc., Actavis Elizabeth LLC. (Attachments: # 1 Exhibit A)(Fineman, Steven) Modified on 6/6/2012 (nms). (Entered: 05/01/2012)

2012-05-01

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 05/01/2012)

2012-05-01

1

View

ORAL ORDER SETTING RULE 16(b) TELECONFERENCE: IT IS HEREBY ORDERED that: (1) A scheduling teleconference pursuant to Fed. R. Civ. P. 16(b) will be held on Friday, May 18, 2012, at 2:00 p.m. Counsel for Plaintiff(s) shall initiate the call to Chambers of Christopher J. Burke by dialing 302-573-4595.(2) For the purpose of being prepared the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal to the Court no later than noon on May 17, 2012. The Court's form scheduling order is posted at http://www.ded.uscourts.gov (see Chambers, Judge Burke, Forms). (3) If there are disputed issues between the parties regarding the content of the Scheduling Order, the parties should note those areas of dispute in the Proposed Order, along with their proposals for the language the Court should adopt as to that issue. In addition, the parties may each separately file a letter (of no more than two single-spaced pages) setting forth their position as to these disputed issues. Ordered by Judge Christopher J. Burke on 5/4/2012. (dlk)(dlk)

2012-05-04

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Stephen R. Howe, Marc N. Zubick, Terrence J. Connolly and Gina R. Gencarelli - filed by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Kenneth G. Schuler Attorney Certification, # 2 Stephen R. Howe Attorney Certification, # 3 Marc N. Zubick Attorney Certification, # 4 Terrence J. Connolly Attorney Certification, # 5 Gina R. Gencarelli Attorney Certification)(Fineman, Steven) (Entered: 05/16/2012)

2012-05-16

1

View

ORAL ORDER: At the request of counsel, the scheduling teleconference pursuant to Fed. R. Civ. P. 16(b) set for Friday, May 18, 2012, is cancelled. A Rule 16 Scheduling Teleconference is set for 5/31/2012 at 09:00 AM before Judge Christopher J. Burke. Counsel for Plaintiff(s) shall initiate the call to Chambers of Christopher J. Burke by dialing 302-573-4595. Parties shall submit their Proposed Scheduling Order no later than 4:30 p.m. on 5/23/12. Ordered by Judge Christopher J. Burke on 5/16/2012. (dlk)

2012-05-16

1

No Actions

ANSWER to 14 Answer to Complaint, and Counterclaims, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 6/6/2012 (nms). (Entered: 05/22/2012)

2012-05-22

1

View

Joint Letter to The Honorable Christopher J. Burke from Michael P. Kelly, Esq. regarding The Parties' Joint Scheduling Proposal and Issues to be Addressed during the May 31, 2012 Teleconference. (Attachments: # 1 [Proposed] Scheduling Order)(Kelly, Michael) (Entered: 05/23/2012)

2012-05-23

1

View

ORAL ORDER: The scheduling teleconference pursuant to Fed. R. Civ. P. 16(b) set for 5/31/2012 before Judge Christopher J. Burke is cancelled. The Court will review the Proposed Scheduling Order submitted by the parties and reschedule the teleconference for a date to be determined. Ordered by Judge Christopher J. Burke on 5/29/2012. (dlk)

2012-05-29

1

No Actions

SO ORDERED D.I. 16 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Stephen R. Howe, Marc N. Zubick, Terrence J. Connolly and Gina R. Gencarelli filed by Actavis Elizabeth LLC, Actavis Inc. Ordered by Judge Christopher J. Burke on 5/30/2012. (dlk)

2012-05-30

1

No Actions

STIPULATION requesting that any and all papers containing confidential information be filed under seal pending the entry of a protective order by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 05/31/2012)

2012-05-31

1

View

MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c) - filed by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Proposed Order)(Fineman, Steven) Modified on 6/6/2012 (nms). (Entered: 05/31/2012)

2012-05-31

1

View

SEALED OPENING BRIEF in Support re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c), filed by Actavis Elizabeth LLC, Actavis Inc..Answering Brief/Response due date per Local Rules is 6/18/2012. (Fineman, Steven) Modified on 6/6/2012 (nms). (Entered: 05/31/2012)

2012-05-31

1

View

SEALED DECLARATION of Gina R. Gencarelli re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c), by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) Modified on 6/6/2012 (nms). (Entered: 05/31/2012)

2012-05-31

1

View

SO ORDERED D.I. 19 Stipulation filed by Actavis Elizabeth LLC, Actavis Inc.. Ordered by Judge Christopher J. Burke on 5/31/2012. (dlk)

2012-05-31

1

No Actions

REDACTED VERSION of 21 Opening Brief in Support, by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 06/04/2012)

2012-06-04

1

View

REDACTED VERSION of 22 Declaration, of Gina R. Gencarelli by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 06/04/2012)

2012-06-04

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's First Set of Requests for Production to Plaintiffs Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, and Novartis Pharma AG by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 06/04/2012)

2012-06-04

1

View

Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)

2012-06-06

1

No Actions

ORAL ORDER REFERRING CASE to Magistrate Judge Christopher J. Burke: IT IS HEREBY ORDERED that the above captioned case is referred to Magistrate Judge Christopher J. Burke to hear and resolve all pretrial matters, up to and including the resolution of case-dispositive motions, subject to 28 U.S.C. § 636(b) and any further Order of the Court; all subsequent filings in this action shall be captioned as follows: Civil Action No. 12-366-RGA-CJB. Ordered by Judge Richard G. Andrews on 6/6/2012. Motions referred to Christopher J. Burke.(nms)

2012-06-06

1

No Actions

ORAL ORDER Resetting Telephonic Scheduling Conference: A Scheduling Teleconference pursuant to Fed. R. Civ. P. 16(b) is set for 6/15/2012 at 02:30 PM before Judge Christopher J. Burke. Ordered by Judge Christopher J. Burke on 6/12/2012. (dlk)

2012-06-13

1

No Actions

STIPULATION TO EXTEND TIME Plaintiffs' Response to Defendants' Rule 12(c) Motion for Judgment on the Pleadings and Defendants' Reply in Support Thereof to June 25, 2012 (Plaintiffs' Response) and July 12, 2012 (Defendants' Reply) - filed by Actavis Elizabeth LLC, Actavis Inc., Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 06/15/2012)

2012-06-15

1

View

Minute Entry for proceedings held before Judge Christopher J. Burke - Scheduling Conference held on 6/15/2012. The parties discussed their proposed positions with regards to a schedule in this matter. The Court will issue a scheduling order. (Court Reporter Heather Troizzi, Hawkins.) (dlk)

2012-06-15

1

No Actions

SCHEDULING ORDER: Joinder of Parties due by 3/4/2013. Amended Pleadings due by 3/4/2013. Discovery due by 5/3/2013. Status Report due by 1/17/2013. Tutorial on the technology due by 1/14/2013. Dispositive Motions due by 9/18/2013. Claim Construction Opening Brief due by 1/14/2013. Claim Construction Answering Brief due by 2/4/2013. Claim Construction Reply Brief due by 2/11/2013. Claim Construction Surreply Brief due by 2/19/2013. A Markman Hearing is set for 3/19/2013 at 10:00 AM in Courtroom 6C before Judge Christopher J. Burke. The Pretrial Conference and Trial dates are to be determined. Signed by Judge Christopher J. Burke on 6/18/2012. (dlk) (Entered: 06/18/2012)

2012-06-18

1

View

SO ORDERED D.I. 26 STIPULATION TO EXTEND TIME Plaintiffs' Response to Defendants' Rule 12(c) Motion for Judgment on the Pleadings and Defendants' Reply in Support Thereof. Set Briefing Schedule: re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)). (Answering Brief due 6/25/2012., Reply Brief due 7/12/2012.). Ordered by Judge Christopher J. Burke on 6/18/2012. (dlk)

2012-06-18

1

No Actions

CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. (dlk)

2012-06-18

1

No Actions

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/20/2012)

2012-06-20

1

View

NOTICE OF SERVICE of Defendant Actavis, Inc. and Actavis Elizabeth LLC's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and D. Del. LR 16.2 by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 06/20/2012)

2012-06-20

1

View

SEALED ANSWERING BRIEF in Opposition re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)) filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.Reply Brief due date per Local Rules is 7/5/2012. (Silver, Daniel) (Entered: 06/25/2012)

2012-06-25

1

View

Pro Hac Vice Attorney Gina R. Gencarelli,Terrence J. Connolly,Marc N. Zubick,Kenneth G. Schuler,Stephen R. Howe for Actavis Inc. added for electronic noticing. (rbe)

2012-06-25

1

No Actions

REDACTED VERSION of 30 Answering Brief in Opposition, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/02/2012)

2012-07-02

1

View

NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Production and (2) Plaintiffs' First Set of Requests for the Production of Documents and Things to Defendants Actavis, Inc. and Actavis Elizabeth, LLC by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/09/2012)

2012-07-09

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's First Set of Interrogatories to Plaintiffs Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, and Novartis Pharma AG by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 07/09/2012)

2012-07-09

1

View

STIPULATION TO EXTEND TIME to file reply brief in support of Defendants' Motion for Judgment of Non-Infringement to July 16, 2012 - filed by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 07/11/2012)

2012-07-11

1

View

NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/11/2012)

2012-07-11

1

View

PROPOSED Protective Order, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A)(Silver, Daniel) Modified on 7/12/2012 (nms). (Entered: 07/12/2012)

2012-07-12

1

View

SO ORDERED D.I. 34 STIPULATION TO EXTEND TIME to file reply brief in support of Defendants' Motion for Judgment of Non-Infringement to July 16, 2012 (D.I. 20 Reply Brief due 7/16/2012.). Ordered by Judge Christopher J. Burke on 7/12/2012. (dlk)

2012-07-12

1

No Actions

SEALED REPLY BRIEF re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)) filed by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 07/16/2012)

2012-07-16

1

View

SO ORDERED D.I. 36 Protective Order filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 7/16/2012. (dlk)

2012-07-16

1

No Actions

REQUEST for Oral Argument by Actavis Elizabeth LLC, Actavis Inc. re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)). (Fineman, Steven) (Entered: 07/18/2012)

2012-07-18

1

View

REDACTED VERSION of 37 Reply Brief in Further Support of Defendants' Motion for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c) by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 07/18/2012)

2012-07-18

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Second Set of Interrogatories to Plaintiffs Novartis Phamaceuticals Corporation, Novartis Corporation, Novartis AG, and Novartis Pharma AG by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 07/24/2012)

2012-07-24

1

View

Joint Proposed Order for Discovery of Electronically Stored Information ("ESI") - by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/31/2012 (nms). (Entered: 07/31/2012)

2012-07-31

1

View

NOTICE of Appearance by Jaclyn Levy on behalf of Actavis Elizabeth LLC, Actavis Inc. (Levy, Jaclyn) (Entered: 07/31/2012)

2012-07-31

1

View

SO ORDERED D.I. 41 Order For Discovery Of Electornically Stored Information filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 7/31/2012. (dlk)

2012-07-31

1

No Actions

ORDER Setting Teleconference : A Telephone Conference is set for 8/28/2012 at 10:00 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 8/2/2012. (dlk) (Entered: 08/02/2012)

2012-08-02

1

View

NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 08/13/2012)

2012-08-13

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Responses to Plaintiffs' First Set of Interrogatories by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 08/13/2012)

2012-08-13

1

View

NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' First Set of Interrogatories by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/13/2012)

2012-08-13

1

View

NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions For Defendant Actavis, Inc. and Actavis Elizabeth LLC by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/17/2012)

2012-08-17

1

View

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Order for Discovery of Electronically Stored Information; Plaintiffs' Responses to Defendants' Second Set of Interrogatories; Plaintiffs' Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/23/2012)

2012-08-23

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Initial ESI Disclosures by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 08/23/2012)

2012-08-23

1

View

ORAL ORDER Setting Hearing on Motion D.I. 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)) : A Motion Hearing is set for 10/4/2012 at 10:00 AM in Courtroom 6C before Judge Christopher J. Burke. The Court has allocated one (1) hour per side for argument. Ordered by Judge Christopher J. Burke on 8/30/2012. (dlk)

2012-09-10

1

No Actions

STIPULATION TO EXTEND TIME regarding the dates set forth in Paragraph (f)(2) of the Scheduling Order (D.I. 27) to - filed by Actavis Elizabeth LLC, Actavis Inc.. (Levy, Jaclyn) (Entered: 09/17/2012)

2012-09-17

1

View

ORDER Setting Teleconference: A Telephone Conference is set for 2/4/2013 at 11:30 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 9/18/2012. (dlk) (Entered: 09/18/2012)

2012-09-18

1

View

SO ORDERED D.I. 50 STIPULATION TO EXTEND TIME regarding the dates set forth in Paragraph (f)(2) of the Scheduling Order (D.I. 27) to filed by Actavis Elizabeth LLC, Actavis Inc.. Ordered by Judge Christopher J. Burke on 9/18/2012. (dlk)

2012-09-19

1

No Actions

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Preliminary Invalidity and Unenforceability Contentions by Actavis Elizabeth LLC, Actavis Inc..(Levy, Jaclyn) (Entered: 09/24/2012)

2012-09-24

1

View

MOTION for Pro Hac Vice Appearance of Attorney Henry Gu - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification of Pro hac vice)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 10/01/2012)

2012-10-01

1

View

NOTICE of Appearance by Daniel J. Brown on behalf of Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation (Brown, Daniel) (Entered: 10/01/2012)

2012-10-01

1

View

NOTICE OF SERVICE of Plaintiffs' First Supplemental Reponses to Defendants' First Set of Interrogatories (2, 3, and 4) by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 10/01/2012)

2012-10-01

1

View

SO ORDERED D.I. 53 MOTION for Pro Hac Vice Appearance of Attorney Henry Gu filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 10/4/2012. (dlk)

2012-10-04

1

No Actions

Minute Entry for proceedings held before Judge Christopher J. Burke - Motion Hearing held on 10/4/2012 re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)) filed by Actavis Elizabeth LLC, Actavis Inc. Written decision to follow. (Court Reporter Deanna Warner(Hawkins).) (dlk)

2012-10-04

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Alexander G. Piller - filed by Actavis Elizabeth LLC, Actavis Inc.. Motions referred to Christopher J. Burke.(Levy, Jaclyn) (Entered: 10/11/2012)

2012-10-11

1

View

Official Transcript of Motion for Judgment on the Pleadings held on 10-04-1 before Judge Chirstopher J. Burke. Court Reporter/Transcriber Deanna Warner. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/5/2012. Redacted Transcript Deadline set for 11/15/2012. Release of Transcript Restriction set for 1/14/2013. (lad) (Entered: 10/15/2012)

2012-10-15

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Preliminary Noninfringement Contentions by Actavis Elizabeth LLC, Actavis Inc..(Levy, Jaclyn) (Entered: 10/16/2012)

2012-10-16

1

View

SO ORDERED D.I. 56 MOTION for Pro Hac Vice Appearance of Attorney Alexander G. Piller filed by Actavis Elizabeth LLC, Actavis Inc. Ordered by Judge Christopher J. Burke on 10/22/2012. (dlk)

2012-10-22

1

No Actions

Pro Hac Vice Attorney Alexander G. Piller for Actavis Inc. added for electronic noticing. (dmp, )

2012-10-23

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Shirley Cantin and Attorney Kelli Powell - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Pro Hac Vice Certification of Shirley Cantin, # 2 Pro Hac Vice Certification of Kelli Powell)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 11/30/2012)

2012-11-30

1

View

NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses to Defendants' Second Set of Interrogatories by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/30/2012)

2012-11-30

1

View

Letter to The Honorable Christopher J. Burke from Steven J. Fineman regarding pending motion for judgment of non-infringement. (Attachments: # 1 Plaintiffs' Claim Construction Issue Identification)(Fineman, Steven) (Entered: 12/03/2012)

2012-12-03

1

View

REPORT AND RECOMMENDATIONS recommending DENIAL of D.I. 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)) filed by Actavis Elizabeth LLC, Actavis Inc.. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 12/26/2012. Because this Report and Recommendation may contain confidential information, it has been released under seal, pending review by the parties to allo w them to submit a single, jointly proposed, redacted version (if necessary) of the R & R. Any such redacted version shall be submitted no later than December 12, 2012 for review by the Court. The Court will subsequently issue a publicly-available version.. Signed by Judge Christopher J. Burke on 12/5/2012. (dlk) Unsealed 12/13/12 Modified on 12/13/2012 (dlk).

2012-12-05

1

Download

SO ORDERED D.I. 59 MOTION for Pro Hac Vice Appearance of Attorney Shirley Cantin and Attorney Kelli Powell filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation Ordered by Judge Christopher J. Burke on 12/5/2012. (dlk)

2012-12-05

1

No Actions

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Third Set of Interrogatories to Plaintiffs Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, and Novartis Pharma AG by Actavis Elizabeth LLC, Actavis Inc..(Levy, Jaclyn) (Entered: 12/13/2012)

2012-12-13

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's First Set of Requests for Admission to Plaintiffs Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, and Novartis Pharma AG by Actavis Elizabeth LLC, Actavis Inc..(Levy, Jaclyn) (Entered: 12/13/2012)

2012-12-13

1

View

Document Unsealed as no redactions have been proposed. 62 REPORT AND RECOMMENDATIONS re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)) filed by Actavis Elizabeth LLC, Actavis Inc.. (dlk)

2012-12-13

1

No Actions

Pro Hac Vice Attorney Kelli Powell,Shirley Cantin for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

2012-12-13

1

No Actions

Joint CLAIM Construction Chart, by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) Modified on 12/18/2012 (nms). (Entered: 12/14/2012)

2012-12-14

1

View

ORAL ORDER: The REPORT AND RECOMMENDATIONS (D.I. 62 ) recommending Denying of the MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 (D.I. 20 ) is hereby ADOPTED. Ordered by Judge Richard G. Andrews on 12/28/2012. (nms)

2012-12-28

1

No Actions

STIPULATION TO EXTEND TIME the deadline for substantial completion of document production to Thursday, January 24, 2013 - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/07/2013)

2013-01-07

1

View

SO ORDERED D.I. 66 STIPULATION TO EXTEND TIME the deadline for substantial completion of document production to Thursday, January 24, 2013 filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 1/7/2013. (dlk)

2013-01-09

1

No Actions

STIPULATION and Order Amending Scheduling Order by Actavis Elizabeth LLC, Actavis Inc.. (Levy, Jaclyn) (Entered: 01/11/2013)

2013-01-11

1

View

SO ORDERED D.I. 67 Stipulation to amend Markman briefing deadlines. Ordered by Judge Christopher J. Burke on 1/11/2013. (dlk)

2013-01-11

1

No Actions

NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' Third Set of Interrogatories and Plaintiffs' Responses and Objections to Defendants' First Set of Requests for Admission by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 01/17/2013)

2013-01-17

1

View

Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Joint Interim Status Report. (Silver, Daniel) (Entered: 01/17/2013)

2013-01-17

1

View

CLAIM CONSTRUCTION OPENING BRIEF filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/22/2013)

2013-01-22

1

View

NOTICE OF SERVICE of Plaintiffs' Markman Tutorial by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 01/22/2013)

2013-01-22

1

View

MULTI MEDIA DOCUMENT filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation in the form of a CD. Filing related to 71 Notice of Service of Novartis Tutorial. (Media on file in Clerk's Office). (dlk) (Entered: 01/31/2013)

2013-01-23

1

View

NOTICE of Withdrawal of Jaclyn C. Levy as Counsel by Actavis Elizabeth LLC, Actavis Inc. (Levy, Jaclyn) (Entered: 02/08/2013)

2013-02-08

1

View

NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses to Defendants' First Set of Requests for Admission (Nos. 3, 4, 6 & 7) by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 02/11/2013)

2013-02-11

1

View

NOTICE of Appearance by Katharine Crawford Lester on behalf of Actavis Elizabeth LLC, Actavis Inc. (Lester, Katharine) (Entered: 02/12/2013)

2013-02-12

1

View

Defendants' ANSWERING Claim Construction Brief re 70 Claim Construction Opening Brief, filed by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) Modified on 2/13/2013 (nms). (Entered: 02/12/2013)

2013-02-12

1

View

Defendants' Markman Tutorial by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) Modified on 2/13/2013 (dlk). (Entered: 02/12/2013)

2013-02-12

1

View

ORAL ORDER Setting Teleconference: A Telephone Conference is set for 3/5/2013 at 04:00 PM before Judge Christopher J. Burke to discuss time allocations, and other procedural matters relating to the hearing on 3/19/2013. Counsel for Plaintiff shall initiate the call. Ordered by Judge Christopher J. Burke on 2/12/2013. (dlk)

2013-02-12

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Darryl H. Steensma and Parker M. Tresemer - filed by Actavis Elizabeth LLC, Actavis Inc.. Motions referred to Christopher J. Burke.(Fineman, Steven) (Entered: 02/13/2013)

2013-02-13

1

View

NOTICE of filing the following document(s) in multi media format: Defendants Actavis, Inc. and Actavis Elizabeth LLC's Markman Tutorial DVDs. Original material(s) to be filed with the Clerk's Office. Notice filed by Steven J. Fineman on behalf of Actavis Elizabeth LLC, Actavis Inc. (Fineman, Steven) (Main Document 79 replaced on 2/14/2013) (ksr, ). (Entered: 02/14/2013)

2013-02-14

1

View

MULTI MEDIA DOCUMENT filed by Actavis Elizabeth LLC, Actavis Inc. in the form of a CD. Filing related to 79 Notice of Filing Markman Tutorial. (Media on file in Clerk's Office). (dlk) (Entered: 02/14/2013)

2013-02-14

1

View

CORRECTING ENTRY: Pursuant to Counsel's request, the PDF of D.I. 79 has been replaced with the amended version of the filing. (ksr, )

2013-02-14

1

No Actions

REPLY Claim Construction Brief, filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 2/20/2013 (nms). (Entered: 02/19/2013)

2013-02-19

1

View

DECLARATION of Kevin Prussia re 81 Reply Claim Construction Brief, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Silver, Daniel) Modified on 2/20/2013 (nms). (Entered: 02/19/2013)

2013-02-19

1

View

SO ORDERED D.I. 78 MOTION for Pro Hac Vice Appearance of Attorney Darryl H. Steensma and Parker M. Tresemer filed by Actavis Elizabeth LLC, Actavis Inc.. Ordered by Judge Christopher J. Burke on 2/21/2013. (dlk)

2013-02-21

1

No Actions

Sur-Reply Claim Construction Brief, filed by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) Modified on 2/28/2013 (nms). (Main Document 83 replaced on 3/1/2013) (dlk). (Entered: 02/27/2013)

2013-02-27

1

View

Joint APPENDIX in Support of Claim Construction Briefing (see 81 Reply Brief, 76 Claim Construction Answering Brief, 70 Claim Construction Opening Brief, 83 Reply Brief) by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Tabs 1-6, # 2 Tabs 7-10, # 3 Tab 11, # 4 Tab 12 Part 1 of 2, # 5 Tab 12 Part 2 of 2, # 6 Tabs 13-21)(Silver, Daniel) Modified on 3/4/2013 (nms). (Entered: 03/01/2013)

2013-03-01

1

View

Remark: PDF found at D.I. 83 has been swapped out at the request of the filer. (dlk)

2013-03-01

1

No Actions

MOTION to Amend 14 Counterclaims - filed by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2 (Part 1), # 3 Exhibit 2 (Part 2), # 4 Proposed Order, # 5 Certification Local Rule 7.1.1)Motions referred to Christopher J. Burke.(Fineman, Steven) Modified on 3/5/2013 (nms). (Entered: 03/04/2013)

2013-03-04

1

View

FIRST AMENDED ANSWER AND COUNTERCLAIMS against Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation by Actavis Inc., Actavis Elizabeth LLC.(dlk) (Entered: 03/05/2013)

2013-03-05

1

View

Minute Entry for proceedings held before Judge Christopher J. Burke - Telephone Conference held on 3/5/2013 to discuss preparations for the Markman Hrg. set for 3/19/13 at 10:00. Each side is alloted 1 hour for presentation and shall by March 14, 2013, advise the Court regarding the order for presentations. (Court Reporter Heather Troizzi (Hawkins)) (dlk)

2013-03-05

1

No Actions

Pro Hac Vice Attorney Parker M. Tresemer,Darryl H. Steensma for Actavis Inc. added for electronic noticing. (els)

2013-03-05

1

No Actions

SO ORDERED D.I. 85 MOTION to Amend/Correct 14 Answer to Complaint, Counterclaim,, Defendants Actavis, Inc. and Actavis Elizabeth LLC's Unopposed Motion to Amend Counterclaim filed by Actavis Elizabeth LLC, Actavis Inc.. Signed by Judge Christopher J. Burke on 3/5/2013. (dlk)

2013-03-05

1

No Actions

Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esquire regarding Markman hearing joint proposal. (Silver, Daniel) (Entered: 03/12/2013)

2013-03-12

1

View

Minute Entry for proceedings held before Judge Christopher J. Burke - Markman Hearing held on 3/19/2013. The Court ordered the parties to discuss the case schedule and to file a joint stipulation regarding any changes to the schedule. As discussed, submissions regarding exhibits shall be made by 3/26/2013. (Court Reporter Taneha Carroll (Hawkins).) (dlk)

2013-03-19

1

No Actions

NOTICE to Take Deposition of Defendants Actavis, Inc. and Actavis Elizabeth LLC on April 23, 2013 by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 03/20/2013)

2013-03-20

1

View

NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission and Plaintiffs' Second Set of Interrogatories to Defendants Actavis, Inc. and Actavis Elizabeth LLC by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 03/21/2013)

2013-03-21

1

View

NOTICE to Take Deposition of Plaintiffs Novartis Pharmacueticals Corporation, Novartis Corporation, Novartis AG,and Novartis Pharma AG on April 5, 2013 by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Exhibit A)(Lester, Katharine) (Entered: 03/21/2013)

2013-03-21

1

View

ANSWER to 86 Answer to Counterclaims, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 3/25/2013 (nms). (Entered: 03/22/2013)

2013-03-22

1

View

Letter to The Honorable Christopher J. Burke from Steven J. Fineman regarding supplemental response to Markman hearing - re Markman Hearing,. (Fineman, Steven) (Entered: 03/26/2013)

2013-03-26

1

View

Letter to The Honorable Christopher J. Burke from Daniel M. Silver regarding supplemental response to Markman hearing. (Silver, Daniel) (Entered: 03/26/2013)

2013-03-26

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed R. Civ. P. 30(b)(6) by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 04/09/2013)

2013-04-09

1

View

NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants Actavis, Inc. and Actavis Elizabeth LLC's Rule 30(b)(6) Notice of Deposition by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 04/09/2013)

2013-04-09

1

View

STIPULATION TO EXTEND TIME Various Case Deadlines - See Stipulation for Details to - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Letter to The Honorable Christopher J. Burke Re: Stipulation and [Proposed] Order to Modify Scheduling Order)(Silver, Daniel) (Entered: 04/15/2013)

2013-04-15

1

View

SO ORDERED D.I. 96 STIPULATION TO EXTEND Various Case Deadlines - filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation, with the amendment that a Pretrial Conference is set for 1/10/2014 at 08:30 AM in Courtroom 6A before Judge Richard G. Andrews and a Bench Trial is set for 1/27/2014 at 09:30 AM in Courtroom 6A before Judge Richard G. Andrews. (See Stipulation for details) Ordered by Judge Christopher J. Burke on 4/23/2013. (dlk)

2013-04-23

1

No Actions

NOTICE OF SERVICE of Objections and Responses to Plaintiffs' Second Set of Interrogatories to Actavis, Inc. and Actavis Elizabeth LLC by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 04/25/2013)

2013-04-25

1

View

NOTICE OF SERVICE of Objections and Responses to Plaintiffs' FIrst Set of Requests for Admission to Actavis, Inc. and Actavis Elizabeth LLC by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 04/25/2013)

2013-04-25

1

View

NOTICE to Take Deposition of Dr. Rene Lattmann on May 16, 2013 by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 04/30/2013)

2013-04-30

1

View

NOTICE to Take Deposition of Dr. Johann Peter Nick on May 8, 2013 by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 04/30/2013)

2013-04-30

1

View

NOTICE to Take Deposition of Peter Waibel on June 10, 2013 by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 05/13/2013)

2013-05-13

1

View

NOTICE to Take Deposition of Rebecca Jolley on June 7, 2013 by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 05/13/2013)

2013-05-13

1

View

NOTICE to Take Deposition of Joseph Borovian on June 5, 2013 at 9:00 a.m. by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 05/16/2013)

2013-05-16

1

View

NOTICE to Take Deposition of Krista McKerracher on July 11, 2013 at 9:00 AM by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 05/23/2013)

2013-05-23

1

View

MOTION for Pro Hac Vice Appearance of Attorney Timothy A. Cook - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Pro Hac Vice Certification of Timothy Cook)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 05/23/2013)

2013-05-23

1

View

NOTICE to Take Deposition of Charlene Salmorin on June 6, 2013 by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 05/24/2013)

2013-05-24

1

View

SO ORDERED D.I. 105 MOTION for Pro Hac Vice Appearance of Attorney Timothy A. Cook filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 5/24/2013. (dlk)

2013-05-24

1

No Actions

NOTICE of Change of Address by Daniel M. Silver (Silver, Daniel) (Entered: 05/28/2013)

2013-05-28

1

View

NOTICE to Take Deposition of Charlene Salmorin on June 6, 2013 by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 05/28/2013)

2013-05-28

1

View

Pro Hac Vice Attorney Timothy Cook for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

2013-05-30

1

No Actions

NOTICE to Take Deposition of Alfred Liang, Meena Venugopal, Craig Jones, Janka Jadeja, and Robert Bonkowski on June 12, 2013, June 13, 2013, June 18, 2013, June 19, 2013 and July 9, 2013 respectively by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 05/31/2013)

2013-05-31

1

View

NOTICE to Take Deposition of Charlene Salmorin on June 26, 2013 by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/06/2013)

2013-06-06

1

View

NOTICE to Take Deposition of Alfred Liang on July 9, 2013 by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/17/2013)

2013-06-17

1

View

NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' Second Set of Interrogatories to Actavis, Inc. and Actavis Elizabeth LLC by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 06/17/2013)

2013-06-17

1

View

NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses to Defendants' Third Set of Interrogatories (Nos. 16-17) and Plaintiffs' Second Supplemental Responses to Defendants' Second Set of Interrogatories by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/18/2013)

2013-06-18

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's First Supplemental Responses to Plaintiffs' First Set of Interrogatories by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 06/18/2013)

2013-06-18

1

View

MOTION for Teleconference to Resolve Discovery Dispute - filed by Actavis Elizabeth LLC, Actavis Inc.. Motions referred to Christopher J. Burke.(Fineman, Steven) (Entered: 07/03/2013)

2013-07-03

1

View

[SEALED] Letter to The Honorable Christopher J. Burke from Steven J. Fineman regarding discovery dispute - re Set/Reset Hearings. (Attachments: # 1 Exhibit A-J, # 2 Certificate of Service)(Fineman, Steven) (Entered: 07/03/2013)

2013-07-03

1

View

Set/Reset Hearings: A Discovery Dispute Teleconference is set for 7/9/2013 at 03:00 PM before Judge Christopher J. Burke. (mlc)

2013-07-03

1

No Actions

[SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esquire regarding July 9, 2013 teleconference. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Certificate of Service)(Silver, Daniel) (Entered: 07/05/2013)

2013-07-05

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's First Supplemental Objections and Responses to Plaintiffs' First Set of Requests For Admission to Acatvis, Inc. and Actavis Elizabeth LLC by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 07/08/2013)

2013-07-08

1

View

ORAL ORDER: For the reasons set forth in the Court's July 9, 2013 teleconference with the parties, the Court GRANTS Defendants' request for an extension to certain Scheduling Order-related deadlines as follows: Fact discovery cut-off deadline shall be extended to August 1, 2013; Expert discovery cut-off deadline shall be extended to December 16, 2013; Opening expert reports deadline shall be extended to September 2, 2013; Rebuttal expert reports deadline shall be extended to October 12, 2013; Reply expert reports deadline shall be extended to November 7, 2013; and all and final supplementation under FRCP 26(e), unless good cause shown upon a motion for leave, shall be extended to December 5, 2013. With respect to any new fact discovery sought by Defendants prior to August 1, 2013, such discovery shall be reasonably related to the documents produced by Plaintiffs on June 20, 2013. Defendants shall identify any additional deponents and deponent topics on which they seek to take deposition discovery by no later than July 17, 2013. Ordered by Judge Christopher J. Burke on 7/9/2013. (dlk)

2013-07-09

1

No Actions

Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Dispute Teleconference held on 7/9/2013. After hearing from both parties, teh Court Granted Defendants' request for an extension of certain Scheudling ORder deadlines. The Court will issue an Order. (Court Reporter Taneha (Hawkins)) (dlk)

2013-07-09

1

No Actions

REDACTED VERSION of 116 Letter by Actavis Elizabeth LLC, Actavis Inc.. (Lester, Katharine) (Entered: 07/10/2013)

2013-07-10

1

View

REDACTED VERSION of 117 Letter, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/12/2013)

2013-07-12

1

View

STIPULATION TO EXTEND TIME Service of expert reports on issues for which the parties have the burden of proof; Service of rebuttal expert reports; Service of reply expert reports to respond to secondary considerations raised by Plaintiffs' rebutal expert reports; Final FRCP 26(e) Supplementation; Completion of expert discovery to September 4, 2013; October 15, 2013; November 11, 2013; December 6, 2013; December 17, 2013 respectively - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/17/2013)

2013-07-17

1

View

Supplemental NOTICE of Fed. R. Civ. P. 30(B)(6) Deposition of Plaintiffs Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, and Novartis Pharma AG on July 25 and 26, 2013 by Actavis Elizabeth LLC, Actavis Inc. (Attachments: # 1 Exhibit A)(Lester, Katharine) (Entered: 07/17/2013)

2013-07-17

1

View

SO ORDERED, re 121 STIPULATION TO EXTEND TIME Service of expert reports on issues for which the parties have the burden of proof; Service of rebuttal expert reports; Service of reply expert reports to respond to secondary considerations raised by Plaintiffs' rebuttal filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 7/17/2013. (dlk)

2013-07-18

1

No Actions

NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Supplemental Notice of Rule 30(b)(6) Deposition by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/19/2013)

2013-07-19

1

View

MOTION for Teleconference to Resolve Discovery Dispute - filed by Actavis Elizabeth LLC, Actavis Inc.. Motions referred to Christopher J. Burke.(Fineman, Steven) (Entered: 08/13/2013)

2013-08-13

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Second Supplemental Responses to Plaintiffs' First Set of Interrogatories by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 08/13/2013)

2013-08-13

1

View

Set/Reset Hearings: A Discovery Dispute Teleconference is set for 8/21/2013 at 03:00 PM before Judge Christopher J. Burke. (dlk)

2013-08-13

1

No Actions

[SEALED] Letter to The Honorable Christopher J. Burke from Steven J. Fineman regarding discovery dispute - re 124 MOTION for Teleconference to Resolve Discovery Dispute . (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13)(Fineman, Steven) (Main Document 126 replaced on 8/19/2013) (dlk). (Attachment 10 replaced on 8/19/2013) (dlk). (Entered: 08/14/2013)

2013-08-14

1

View

[SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esquire regarding discovery dispute - re 126 Letter,,. (Attachments: # 1 Exhibit 1-10)(Silver, Daniel) (Entered: 08/19/2013)

2013-08-19

1

View

[SEALED] DECLARATION Kevin Prussia re 127 Letter, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-6)(Silver, Daniel) Modified on 8/19/2013 (nms). (Entered: 08/19/2013)

2013-08-19

1

View

Remark: PDFs of D.I. 126 and Exhibit 10 have been replaced at the request of counsel (dlk)

2013-08-19

1

No Actions

REDACTED VERSION of 126 Letter, by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Exhibits 1-13)(Fineman, Steven) Modified on 8/22/2013 (nms). (Entered: 08/21/2013)

2013-08-21

1

View

Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Dispute Teleconference (D.I. 124) held on 8/21/2013. The Court ordered parties to further meet and confer and provide a status report by 8/27/13. (Court Reporter Heather Troizzi (Hawkins).) (dlk)

2013-08-21

1

No Actions

REDACTED VERSION of 127 Letter by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-10)(Silver, Daniel) (Entered: 08/26/2013)

2013-08-26

1

View

REDACTED VERSION of 128 Declaration by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-6)(Silver, Daniel) (Entered: 08/26/2013)

2013-08-26

1

View

[SEALED] Letter to The Honorable Christopher J. Burke from Steven J. Fineman regarding Joint Status Report - re Discovery Conference,. (Fineman, Steven) (Entered: 08/28/2013)

2013-08-28

1

View

REDACTED VERSION of 132 Letter by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 09/04/2013)

2013-09-04

1

View

NOTICE OF SERVICE of Opening Expert Report of Dr. Ellis J. Neufeld by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/04/2013)

2013-09-04

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Opening Expert Report of David A. Kessler, M.D. by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 09/04/2013)

2013-09-04

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Opening Expert Report of Jayesh Mehta, M.D. by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 09/04/2013)

2013-09-04

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Opening Expert Report of Kenneth N. Raymond, Ph.D. by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 09/04/2013)

2013-09-04

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Opening Expert Report of David I. Schuster, Ph.D. by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 09/04/2013)

2013-09-04

1

View

[SEALED] ORDER regarding issues raised in D.I. 124 MOTION for Teleconference to Resolve Discovery Dispute . Signed by Judge Christopher J. Burke on 9/5/2013. Because this Order may contain confidential information, it has been released under seal, pending review by the parties to allow them to submit a single, jointly proposed, redacted version (if necessary) of the Order. Any such redacted version shall be submitted no later than September 9, 2013 for review by the Court. The Court will subsequently issue a publicly-available version of its Order.(dlk) Modified on 9/5/2013 (dlk). (Entered: 09/05/2013)

2013-09-05

1

View

[SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esquire regarding Redactions to Order dated September 5, 2013 - re 139 Order on Motion for Miscellaneous Relief,,. (Attachments: # 1 Proposed Redactions, # 2 Certificate of Service)(Silver, Daniel) (Entered: 09/09/2013)

2013-09-09

1

View

REDACTED VERSION of D.I. 139 Order on Motion for Miscellaneous Relief. (dlk) (Entered: 09/10/2013)

2013-09-10

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's First Supplemental Objections and Responses to Plaintiffs' Second Set of Interrogatories by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 09/10/2013)

2013-09-10

1

View

REDACTED VERSION of 140 Letter, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits, # 2 Certificate of Service)(Silver, Daniel) (Entered: 09/16/2013)

2013-09-16

1

View

NOTICE OF SERVICE of Supplemental Expert Report of Dr. Ellis J. Neufeld, M.D., Ph.D. by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 10/09/2013)

2013-10-09

1

View

NOTICE OF SERVICE of Rebuttal Expert Reports of Drs. Neufeld, Nathan and Hider by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 10/15/2013)

2013-10-15

1

View

NOTICE OF SERVICE of Defendants Rebuttal Expert Report of Jayesh Mehta, M.D. with Exhibits A-S by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 10/16/2013)

2013-10-16

1

View

MOTION for Pro Hac Vice Appearance of Attorney John J. Regan - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification by Counsel to Be Admitted Pro Hac Vice)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 10/18/2013)

2013-10-18

1

View

MOTION for Pro Hac Vice Appearance of Attorney Corinne Atton - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification by Counsel to be Admitted Pro Hac Vice)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 10/18/2013)

2013-10-18

1

View

Official Transcript of Markman Hearing held on 03-19-13 before Judge Christopher J. Burke. Court Reporter/Transcriber Taneha Carroll. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/12/2013. Redacted Transcript Deadline set for 11/19/2013. Release of Transcript Restriction set for 1/17/2014. (lad) (Entered: 10/19/2013)

2013-10-19

1

View

SO ORDERED D.I. 147 MOTION for Pro Hac Vice Appearance of Attorney John J. Regan filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation, and D.I. 148 MOTION for Pro Hac Vice Appearance of Attorney Corinne Atton filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 10/24/2013. (dlk)

2013-10-24

1

No Actions

STIPULATION to Extend Time re Various Case Deadlines (See Stipulation for Details), by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 10/28/2013 (nms). (Entered: 10/25/2013)

2013-10-25

1

View

Pro Hac Vice Attorney John J. Regan,Corinne E. Atton for Novartis Pharmaceuticals Corporation added for electronic noticing. (els)

2013-10-25

1

No Actions

SO ORDERED D.I. 150 Stipulation to Extend Time re Various Case Deadlines filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 10/29/2013. (dlk)

2013-10-29

1

No Actions

Set/Reset Deadlines: Pretrial Order due by 1/6/2014. (dlk)

2013-10-29

1

No Actions

NOTICE OF SERVICE of Reply Expert Report of Dr. Ellis J. Neufeld, M.D., Ph.D. Concerning Infringement by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/11/2013)

2013-11-11

1

View

NOTICE OF SERVICE of Defendants Reply Expert Report of Jayesh Mehta, M.D. with Exhibits 1-3 and Reply Expert Report of Kenneth M. Raymond, Ph.D. with Exhibits 1-10 by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 11/12/2013)

2013-11-12

1

View

NOTICE to Take Deposition of Dr. Kenneth N. Raymond, Dr. Jayesh Mehta and Dr. David I. Shuster on December 4, 2013, December 6, 2013 and December 13, 2013, respectively by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/15/2013)

2013-11-15

1

View

NOTICE of Deposition of Plaintiffs' Experts by Actavis Elizabeth LLC, Actavis Inc. (Fineman, Steven) (Entered: 11/15/2013)

2013-11-15

1

View

REPORT AND RECOMMENDATIONS regarding Claim Construction. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 12/9/2013. Signed by Judge Christopher J. Burke on 11/21/2013. (dlk)

2013-11-21

1

Download

ORAL ORDER Setting Hearings: A Status Teleconference is set for 12/2/2013 at 11:00 AM before Judge Christopher J. Burke. Counsel for Plaintiffs shall initiate the call. Ordered by Judge Christopher J. Burke on 11/21/2013. (dlk)

2013-11-21

1

No Actions

NOTICE OF SERVICE of Defendants Supplemental Expert Report of Kenneth N. Raymond, Ph.D. with Exhibits 1-22 by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 11/26/2013)

2013-11-26

1

View

Letter to the Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding the December 2nd, 2013 Status Conference. (Silver, Daniel) (Entered: 11/27/2013)

2013-11-27

1

View

Proposed Revised Protective Order, by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Exhibit A)(Fineman, Steven) Modified on 12/2/2013 (nms). (Entered: 11/27/2013)

2013-11-27

1

View

ORDER Setting Teleconference: A Telephone Conference is set for 12/9/2013 at 10:30 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 12/2/2013. (dlk) (Entered: 12/02/2013)

2013-12-02

1

View

[SEALED] Letter to The Honorable Christopher J. Burke from Steven J. Fineman regarding response to Novartis' November 27 Letter Brief - re 157 Letter. (Attachments: # 1 Exhibit A - G)(Fineman, Steven) (Entered: 12/02/2013)

2013-12-02

1

View

SO ORDERED D.I. 158 Revised Protective Order filed by Actavis Elizabeth LLC, Actavis Inc.. Ordered by Judge Christopher J. Burke on 12/2/2013. (dlk)

2013-12-02

1

No Actions

Minute Entry for proceedings held before Judge Christopher J. Burke - Status Teleconference held on 12/2/2013 to discuss outstanding issues. The Court ordered further briefing on the issue of Plaintiffs' letter motion to strike (D.I. 157). The dispute raised regarding claim construction can be resolved during trial, if necessary. (Court Reporter T. Carroll (Hawkins).) (dlk)

2013-12-02

1

No Actions

Official Transcript of Scheduling Conference held on 06-15-13 before Judge Christopher J. Burke. Court Reporter/Transcriber Heather Triozzi. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/27/2013. Redacted Transcript Deadline set for 1/6/2014. Release of Transcript Restriction set for 3/6/2014. (lad) (Entered: 12/06/2013)

2013-12-06

1

View

[SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Plaintiffs Reply Letter Concerning the Supplemental Raymond Report. (Attachments: # 1 Exhibits A-C, # 2 Certificate of Service (Served December 6, 2013 via email))(Silver, Daniel) (Entered: 12/07/2013)

2013-12-07

1

View

[SEALED] Letter to The Honorable Christopher J. Burke from Seven J. Fineman regarding Actavis' request to file a sur-reply letter - re 160 Letter. (Attachments: # 1 Exhibit 1)(Fineman, Steven) (Entered: 12/09/2013)

2013-12-09

1

View

REDACTED VERSION of 160 Letter, by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Exhibits A-G)(Fineman, Steven) Modified on 12/10/2013 (nms). (Entered: 12/09/2013)

2013-12-09

1

View

OBJECTIONS by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation to 155 REPORT AND RECOMMENDATIONS. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten . (Attachments: # 1 Exhibits 1-2, # 2 Certification of Good Cause)(Silver, Daniel) (Entered: 12/09/2013)

2013-12-09

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLCs Third Supplemental Responses to Plaintiffs First Set of Interrogatories by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 12/10/2013)

2013-12-10

1

View

[SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Requesting Leave to File a Sur-Sur-Reply - re SO ORDERED. (Attachments: # 1 Exhibit 1)(Silver, Daniel) (Entered: 12/11/2013)

2013-12-11

1

View

SO ORDERED granting Actavis' request to file a sur-reply in D.I. 163 Letter. Ordered by Judge Christopher J. Burke on 12/11/2013. (dlk)

2013-12-11

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Mark McBriar and Mat Trachok - filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Pro Hac Verifications)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 12/13/2013)

2013-12-13

1

View

ORAL ORDER: Plaintiffs request to file a sur-sur-reply (D.I. 167 Letter) is granted. In light of the fact that both Defendants sur-reply and Plaintiffs sur-sur-reply address a deposition occurring after the filing of initial letter briefs, the Court finds it appropriate to consider both of these later filings. No further briefing on this issue will be permitted.. Ordered by Judge Christopher J. Burke on 12/13/2013. (mlc)

2013-12-13

1

No Actions

Letter to The Honorable Richard G. Andrews from Daniel M. Silver regarding Submission of Courtesy Copies of all Docket Entries and Submissions Related to. (Silver, Daniel) Modified on 12/16/2013 (nms). (Entered: 12/16/2013)

2013-12-16

1

View

REDACTED VERSION of 162 Letter, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits A-B, # 2 Exhibit C, # 3 Certificate of Service)(Silver, Daniel) (Entered: 12/16/2013)

2013-12-16

1

View

REDACTED VERSION of 167 Letter by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1)(Silver, Daniel) (Entered: 12/18/2013)

2013-12-18

1

View

REDACTED VERSION of 163 Letter, by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Exhibit 1)(Fineman, Steven) Modified on 12/19/2013 (nms). (Entered: 12/18/2013)

2013-12-18

1

View

MEMORANDUM ORDER DENYING Plaintiffs' letter motion (D.I. 157 Letter) to strike the supplemental expert report of Defendants' expert Kenneth N. Raymond, Ph.D. To the extent counsel has objections to the Memorandum Order, they shall be filed no later than December 31, 2013 and any Response shall be filed no later than January 8, 2014. Signed by Judge Christopher J. Burke on 12/23/2013. (mlc) Unsealed on 1/2/2014 (dlk).

2013-12-23

1

Download

RESPONSE TO OBJECTIONS by Actavis Elizabeth LLC, Actavis Inc. re 155 REPORT AND RECOMMENDATIONS. (Fineman, Steven) Modified on 12/30/2013 (nms). (Entered: 12/23/2013)

2013-12-23

1

View

DECLARATION of Gina R. Gencarelli re 174 Response to Objections, by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Exhibit 1)(Fineman, Steven) Modified on 12/30/2013 (nms). (Entered: 12/23/2013)

2013-12-23

1

View

[SEALED] EXHIBIT 2 re 175 Declaration, by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) Modified on 12/30/2013 (nms). (Entered: 12/23/2013)

2013-12-23

1

View

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Prior Art Notice Pursuant to 35 U.S.C. Section 282 filed by Actavis Elizabeth LLC, Actavis Inc..(Lester, Katharine) (Entered: 12/27/2013)

2013-12-27

1

View

Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Your Honor's December 23, 2013 Sealed Memorandum Order - re 173 Memorandum and Order,. (Silver, Daniel) (Entered: 12/30/2013)

2013-12-30

1

View

REDACTED VERSION of 176 Exhibit 2 to Declaration of Gina Gencarelli, by Actavis Elizabeth LLC, Actavis Inc.. (Lester, Katharine) Modified on 12/30/2013 (nms). (Entered: 12/30/2013)

2013-12-30

1

View

Remark: D.I. 173 MEMORANDUM ORDER DENYING Plaintiffs' letter motion (D.I. 157 Letter) to strike the supplemental expert report of Defendants' expert Kenneth N. Raymond, Ph.D. filed on 12/23/13 has been unsealed as no redactions have been requested. (dlk)

2014-01-02

1

No Actions

[SEALED] Proposed Joint Pretrial Order, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11A, # 12 Exhibit 11B, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 16, # 16 Exhibit 17, # 17 Exhibit 18, # 18 Exhibit 19)(Silver, Daniel) Modified on 1/7/2014 (nms). Modified on 1/7/2014 (nms). (Entered: 01/06/2014)

2014-01-06

1

View

SO ORDERED, re 168 MOTION for Pro Hac Vice Appearance of Attorney Mark McBriar and Mat Trachok filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Signed by Judge Richard G. Andrews on 1/6/2014. (nms)

2014-01-06

1

No Actions

ORDER re 155 REPORT AND RECOMMENDATIONS, and Objections 165 and Responses (D.I. 174 ) filed with regard to it (see Order for further details). Signed by Judge Richard G. Andrews on 1/7/2014. (nms) (Entered: 01/08/2014)

2014-01-07

1

View

Pro Hac Vice Attorney Mat Trachok for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

2014-01-07

1

No Actions

Pro Hac Vice Attorney Mark McBriar for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

2014-01-07

1

No Actions

[SEALED] STIPULATION and Proposed Order, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 1/13/2014 (nms). (Entered: 01/10/2014)

2014-01-10

1

View

Minute Entry for proceedings held before Judge Richard G. Andrews - Final Pretrial Conference held on 1/10/2014. Each side is given 10.5 hours to present their cases. Trial will begin at 8:30 AM and end at 5:00 PM each day. (Court Reporter Jennifer Guy - Hawkins Reporting Service.) (ksr, )

2014-01-10

1

No Actions

[SEALED] ORDER Granting 182 Sealed Stipulation, filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Signed by Judge Richard G. Andrews on 1/3/2014. (nms) (Entered: 01/13/2014)

2014-01-13

1

View

REDACTED VERSION of 180 Proposed Pretrial Order,, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11A, # 12 Exhibit 11B, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 16 (A-F), # 16 Exhibit 17 (A-E), # 17 Exhibit 18, # 18 Exhibit 19)(Silver, Daniel) (Entered: 01/13/2014)

2014-01-13

1

View

MOTION for Pro Hac Vice Appearance of Attorney Melissa Brand - filed by Actavis Elizabeth LLC, Actavis Inc.. Motions referred to Christopher J. Burke.(Fineman, Steven) (Entered: 01/16/2014)

2014-01-16

1

View

SO ORDERED D.I. 185 MOTION for Pro Hac Vice Appearance of Attorney Melissa Brand filed by Actavis Elizabeth LLC, Actavis Inc.. Ordered by Judge Christopher J. Burke on 1/17/2014. (dlk) (Entered: 01/17/2014)

2014-01-17

1

View

REDACTED VERSION of 182 Stipulation and Proposed Order, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 1/21/2014 (nms). (Entered: 01/17/2014)

2014-01-17

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Actavis plc (f/k/a Watson Pharmaceuticals) for Actavis Elizabeth LLC filed by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 01/17/2014)

2014-01-17

1

View

[SEALED] STIPULATION Continuing Trial Date (See Stipulation for Details), by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 1/24/2014 (nms). (Entered: 01/24/2014)

2014-01-24

1

View

[SEALED] ORDER Granting 189 Sealed Stipulation and Order Continuing Trial Date, filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Signed by Judge Richard G. Andrews on 1/24/2014.This order is available for pickup at Clerk's Office by local counsel. (nms) (Entered: 01/24/2014)

2014-01-24

1

View

REDACTED VERSION of 189 Stipulation by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/31/2014)

2014-01-31

1

View

[SEALED] Joint STATUS REPORT and Stipulation and Proposed Order - by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 2/7/2014 (nms). (Entered: 02/07/2014)

2014-02-07

1

View

[SEALED] ORDER Granting 192 Joint Status Report and Stipulation and Proposed Order, filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Signed by Judge Richard G. Andrews on 2/7/2014.This order is available for pickup at Clerks Office by local counsel. (nms) (Entered: 02/07/2014)

2014-02-07

1

View

REDACTED VERSION of 192 Joint Status Report, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 2/18/2014 (nms). (Entered: 02/14/2014)

2014-02-14

1

View

[SEALED] Joint STATUS REPORT and Stipulation and [Proposed] Order Maintaining Stay by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 02/21/2014)

2014-02-21

1

View

[SEALED] ORDER Granting 195 Joint Status Report and Stipulation and Proposed Order Maintaining Stay, filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Signed by Judge Richard G. Andrews on 2/21/2014.This order is available for pickup at Clerk's Office by local counsel. (nms) (Entered: 02/24/2014)

2014-02-21

1

View

REDACTED VERSION of 195 Status Report and Stipulation and [Proposed] Order Maintaining Stay, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 3/4/2014 (nms). (Entered: 02/28/2014)

2014-02-28

1

View

[SEALED] Joint Status Report and Stipulation and Proposed Order Maintaing Stay, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 3/10/2014 (nms). (Entered: 03/07/2014)

2014-03-07

1

View

SEALED SO ORDERED, re 198 Sealed Joint Status Report and Stipulation and Proposed Order Maintaining Stay, filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Signed by Judge Richard G. Andrews on 3/10/2014. (nms) Modified on 3/10/2014 (nms). (Entered: 03/10/2014)

2014-03-10

1

View

CORRECTING ENTRY: The docket text for D.I. 199 has been amended to reflect the filing is under seal. (nms)

2014-03-10

1

No Actions

[SEALED] STIPULATION To Stay Case, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 3/13/2014 (nms). (Entered: 03/12/2014)

2014-03-12

1

View

[SEALED] ORDER Granting 200 Stipulation and Order, filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Signed by Judge Richard G. Andrews on 3/13/2014.This order is available for pickup at Clerk's Office by local counsel. (nms) (Entered: 03/13/2014)

2014-03-13

1

View

REDACTED VERSION of 198 Joint Status Report and Stipulation, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 3/14/2014 (nms). (Entered: 03/14/2014)

2014-03-14

1

View

REDACTED VERSION of 200 Stipulation and Order to Stay by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 03/17/2014)

2014-03-17

1

View

Official Transcript of Pretrial Conference held on 01-10-14 before Judge Richard G. Andrews. Court Reporter/Transcriber Jennifer Guy. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 4/15/2014. Redacted Transcript Deadline set for 4/25/2014. Release of Transcript Restriction set for 6/23/2014. (lad) (Entered: 03/25/2014)

2014-03-25

1

View

Stipulation and Order of Dismissal Without Prejudice, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 4/29/2014 (nms). (Entered: 04/28/2014)

2014-04-28

1

View

ORDER Granting 205 Stipulation of Dismissal, filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 4/29/2014. (nms) (Entered: 04/29/2014)

2014-04-29

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,465,504; 6,596,750. (Attachments: # 1 Order)(nms) (Entered: 04/30/2014)

2014-04-30

1

View

ORDER AND NOTICE REGARDING RETURN OF SEALED DOCUMENTS: Pursuant to the attached STANDING ORDER dated January 8, 2013, sealed documents identified on the highlighted docket sheet will be claimed by the FILING party/attorney no later than 7/7/14. Filing attorney or their designee shall CLAIM their sealed documents by sending an E-MAIL, Subject: Return of Sealed Documents, to returnsealeddocs@ded.uscourts.gov, listing the case number and a contact's name, phone number and address. Parties not registered in CM/ECF may call our Help Desk at 302-573-6170 to claim their sealed documents. Once sealed documents are claimed, THE CLERK SHALL prepare receipts and contact filers WHEN THEIR DOCUMENTS ARE READY FOR PICK-UP at the Clerk's Office, 844 N. King Street, Intake Help Desk, Room 4209. Documents not claimed shall be unsealed and handled pursuant to the standing order. (Attachments: # 1 Highlighted Docket Sheet) (cla, ) (Entered: 06/23/2014)

2014-06-23

1

View

ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of McCarter & English : D.I. # 30 (cla, ) (Entered: 06/23/2014)

2014-06-23

1

View

ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Richards, Layton & Finger : D.I. # 21, 22, 37 (cla, ) (Entered: 06/26/2014)

2014-06-26

1

View

Letter to Counsel from Clerk, USDC/DE, dated 6/6/16, regarding return of Tutorial DVD - re 80 Multi Media Document. (rwc) (Entered: 06/06/2016)

2016-06-06

1

View

ACKNOWLEDGMENT OF RECEIPT of 80 Multi Media Document. Acknowledgment filed by Novartis Corporation. (rwc) (Entered: 06/14/2016)

2016-06-14

1

View

Overview

Parties

Defendant

Actavis Group PTC ehf Follow

Represented By

Actavis Group hf Follow

Represented By

Actavis Elizabeth LLC Follow

Represented By

Actavis Inc. Follow

Represented By

Novartis AG Follow

Represented By

Novartis Corporation Follow

Represented By

Novartis Pharmaceuticals Corporation Follow

Represented By

Plaintiff

Novartis Pharma AG Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (lih) (Entered: 03/22/2012)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/8/2012. Date of Expiration of Patent: '504 4/5/2019; '750 6/24/2017.Thirty Month Stay Deadline: 8/8/2014. (lih) (Entered: 03/22/2012)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,465,504; 6,596,750. (lih) (Entered: 03/22/2012)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (lih) (Main Document 5 replaced on 3/22/2012) (lih). (Entered: 03/22/2012)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Corporation identifying Corporate Parent Novartis AG for Novartis Corporation. (lih) (Entered: 03/22/2012)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis AG. (lih) (Entered: 03/22/2012)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (lih) (Entered: 03/22/2012)

No Summons Issued (lih)

CORRECTING ENTRY: The pdf of D.I. 5 has been replaced with the correct version of the document. (lih)

Summons Issued with Magistrate Consent Notice attached as to Actavis Elizabeth LLC on 3/23/2012; Actavis Inc. on 3/23/2012. (rwc)

SUMMONS Returned Executed by Novartis AG, Novartis Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharma AG. Actavis Inc. served on 3/26/2012, answer due 4/16/2012. (Silver, Daniel) (Entered: 03/26/2012)

SUMMONS Returned Executed by Novartis AG, Novartis Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharma AG. Actavis Elizabeth LLC served on 3/26/2012, answer due 4/16/2012. (Silver, Daniel) (Entered: 03/26/2012)

SO ORDERED D.I. 11 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert J. Gunther, Jr., Lisa L. Pirozzolo and Kevin Prussia filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 3/30/2012. (dlk)

ACKNOWLEDGEMENT OF SERVICE Executed Complaint served on Actavis Group hf and Actavis Group PTC EHF on March 30, 2012 Acknowledgement filed by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 04/02/2012)

Pro Hac Vice Attorney Jane M. Love for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

Pro Hac Vice Attorney Lisa J. Pirozzolo,Kevin S. Prussia,Robert J. Gunther, Jr for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

ANSWER to 1 Complaint, and COUNTERCLAIMS against Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation by Actavis Inc., Actavis Elizabeth LLC. (Attachments: # 1 Exhibit A)(Fineman, Steven) Modified on 6/6/2012 (nms). (Entered: 05/01/2012)

Disclosure Statement pursuant to Rule 7.1 filed by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 05/01/2012)

ANSWER to 14 Answer to Complaint, and Counterclaims, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 6/6/2012 (nms). (Entered: 05/22/2012)

Joint Letter to The Honorable Christopher J. Burke from Michael P. Kelly, Esq. regarding The Parties' Joint Scheduling Proposal and Issues to be Addressed during the May 31, 2012 Teleconference. (Attachments: # 1 [Proposed] Scheduling Order)(Kelly, Michael) (Entered: 05/23/2012)

SO ORDERED D.I. 16 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Stephen R. Howe, Marc N. Zubick, Terrence J. Connolly and Gina R. Gencarelli filed by Actavis Elizabeth LLC, Actavis Inc. Ordered by Judge Christopher J. Burke on 5/30/2012. (dlk)

STIPULATION requesting that any and all papers containing confidential information be filed under seal pending the entry of a protective order by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 05/31/2012)

MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c) - filed by Actavis Elizabeth LLC, Actavis Inc.. (Attachments: # 1 Proposed Order)(Fineman, Steven) Modified on 6/6/2012 (nms). (Entered: 05/31/2012)

SEALED DECLARATION of Gina R. Gencarelli re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c), by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) Modified on 6/6/2012 (nms). (Entered: 05/31/2012)

SO ORDERED D.I. 19 Stipulation filed by Actavis Elizabeth LLC, Actavis Inc.. Ordered by Judge Christopher J. Burke on 5/31/2012. (dlk)

REDACTED VERSION of 21 Opening Brief in Support, by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 06/04/2012)

REDACTED VERSION of 22 Declaration, of Gina R. Gencarelli by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 06/04/2012)

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's First Set of Requests for Production to Plaintiffs Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, and Novartis Pharma AG by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 06/04/2012)

Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)

ORAL ORDER Resetting Telephonic Scheduling Conference: A Scheduling Teleconference pursuant to Fed. R. Civ. P. 16(b) is set for 6/15/2012 at 02:30 PM before Judge Christopher J. Burke. Ordered by Judge Christopher J. Burke on 6/12/2012. (dlk)

Minute Entry for proceedings held before Judge Christopher J. Burke - Scheduling Conference held on 6/15/2012. The parties discussed their proposed positions with regards to a schedule in this matter. The Court will issue a scheduling order. (Court Reporter Heather Troizzi, Hawkins.) (dlk)

CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. (dlk)

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/20/2012)

NOTICE OF SERVICE of Defendant Actavis, Inc. and Actavis Elizabeth LLC's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and D. Del. LR 16.2 by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 06/20/2012)

Pro Hac Vice Attorney Gina R. Gencarelli,Terrence J. Connolly,Marc N. Zubick,Kenneth G. Schuler,Stephen R. Howe for Actavis Inc. added for electronic noticing. (rbe)

REDACTED VERSION of 30 Answering Brief in Opposition, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/02/2012)

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's First Set of Interrogatories to Plaintiffs Novartis Pharmaceuticals Corporation, Novartis Corporation, Novartis AG, and Novartis Pharma AG by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 07/09/2012)

STIPULATION TO EXTEND TIME to file reply brief in support of Defendants' Motion for Judgment of Non-Infringement to July 16, 2012 - filed by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 07/11/2012)

NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/11/2012)

PROPOSED Protective Order, by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A)(Silver, Daniel) Modified on 7/12/2012 (nms). (Entered: 07/12/2012)

SO ORDERED D.I. 34 STIPULATION TO EXTEND TIME to file reply brief in support of Defendants' Motion for Judgment of Non-Infringement to July 16, 2012 (D.I. 20 Reply Brief due 7/16/2012.). Ordered by Judge Christopher J. Burke on 7/12/2012. (dlk)

SEALED REPLY BRIEF re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)) filed by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 07/16/2012)

SO ORDERED D.I. 36 Protective Order filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 7/16/2012. (dlk)

REQUEST for Oral Argument by Actavis Elizabeth LLC, Actavis Inc. re 20 MOTION for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c)). (Fineman, Steven) (Entered: 07/18/2012)

REDACTED VERSION of 37 Reply Brief in Further Support of Defendants' Motion for Judgment of Non-Infringement of U.S. Patent No. 6,596,750 Under Federal Rule of Civil Procedure 12(c) by Actavis Elizabeth LLC, Actavis Inc.. (Fineman, Steven) (Entered: 07/18/2012)

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Second Set of Interrogatories to Plaintiffs Novartis Phamaceuticals Corporation, Novartis Corporation, Novartis AG, and Novartis Pharma AG by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 07/24/2012)

Joint Proposed Order for Discovery of Electronically Stored Information ("ESI") - by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/31/2012 (nms). (Entered: 07/31/2012)

NOTICE of Appearance by Jaclyn Levy on behalf of Actavis Elizabeth LLC, Actavis Inc. (Levy, Jaclyn) (Entered: 07/31/2012)

SO ORDERED D.I. 41 Order For Discovery Of Electornically Stored Information filed by Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Corporation. Ordered by Judge Christopher J. Burke on 7/31/2012. (dlk)

ORDER Setting Teleconference : A Telephone Conference is set for 8/28/2012 at 10:00 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 8/2/2012. (dlk) (Entered: 08/02/2012)

NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 08/13/2012)

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Responses to Plaintiffs' First Set of Interrogatories by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 08/13/2012)

NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' First Set of Interrogatories by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/13/2012)

NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions For Defendant Actavis, Inc. and Actavis Elizabeth LLC by Novartis AG, Novartis Corporation, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/17/2012)

NOTICE OF SERVICE of Defendants Actavis, Inc. and Actavis Elizabeth LLC's Initial ESI Disclosures by Actavis Elizabeth LLC, Actavis Inc..(Fineman, Steven) (Entered: 08/23/2012)

STIPULATION TO EXTEND TIME regarding the dates set forth in Paragraph (f)(2) of the Scheduling Order (D.I. 27) to - filed by Actavis Elizabeth LLC, Actavis Inc.. (Levy, Jaclyn) (Entered: 09/17/2012)

Actavis Group PTC ehf

Actavis Group hf

Actavis Elizabeth LLC

Actavis Inc.

Novartis AG

Novartis Corporation

Novartis Pharmaceuticals Corporation

Novartis Pharma AG